← Scroll for more →
Financial Statements — ANRO
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 243.73 | 263.76 | 176.48 | 137.82 | 147.59 | 160.75 | 168.23 | 181.70 | 193.12 | 205.90 |
| Total Current Assets | 247.32 | 269.13 | 177.72 | 139.45 | 149.85 | 163.52 | 169.34 | 183.53 | 195.41 | 208.31 |
| Property, Plant & Equipment | 2.05 | 2.23 | 1.87 | 2.03 | 2.31 | 2.48 | 2.67 | 2.35 | 1.44 | 1.55 |
| Total Non-current Assets* | 6.75 | 7.13 | 6.97 | 7.56 | 8.03 | 8.39 | 8.21 | 8.08 | 1.95 | 1.61 |
| Total Assets | 254.07 | 276.26 | 184.69 | 147.01 | 157.88 | 171.92 | 177.54 | 191.61 | 197.36 | 209.92 |
| Accounts Payable | 4.02 | 3.37 | 1.88 | 2.06 | 1.67 | 1.38 | 1.58 | 2.25 | 1.84 | 2.41 |
| Total Current Liabilities | 16.65 | 13.12 | 11.33 | 9.05 | 8.13 | 7.26 | 10.01 | 14.02 | 9.84 | 8.01 |
| Long-term Debt | 12.42 | 13.89 | 16.17 | 20.31 | 20.12 | 19.94 | 10.25 | 10.16 | 10.06 | 9.96 |
| Total Non-current Liabilities* | 18.17 | 19.77 | 22.22 | 26.40 | 26.34 | 25.56 | 16.07 | 12.54 | 7.74 | 8.81 |
| Total Liabilities | 34.82 | 32.89 | 33.55 | 35.45 | 34.47 | 32.82 | 26.08 | 26.56 | 17.58 | 16.82 |
| Retained Earnings | (255.51) | (227.87) | (201.63) | (185.45) | (171.27) | (153.56) | (138.40) | (123.19) | (106.41) | (90.38) |
| Total Stockholder Equity | 219.25 | 243.37 | 151.14 | 111.56 | 123.41 | 139.10 | 151.46 | 165.05 | 179.78 | 193.10 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research & Development | 22.11 | 20.29 | 12.00 | 10.53 | 13.12 | 9.97 | 10.80 | 13.06 | 13.18 | 9.95 |
| Selling, General & Admin | 7.02 | 6.84 | 5.06 | 4.43 | 5.56 | 5.70 | 6.20 | 5.83 | 5.16 | 4.43 |
| Total Operating Expenses | 29.13 | 27.14 | 17.06 | 14.95 | 18.68 | 15.68 | 17.00 | 18.89 | 18.34 | 14.39 |
| Operating Income | (29.13) | (27.14) | (17.05) | (14.95) | (18.68) | (15.68) | (17.00) | (18.89) | (18.34) | (14.39) |
| Pretax Income* | -- | -- | (16.18) | (14.18) | (17.71) | (15.17) | (15.20) | (16.78) | (16.03) | (13.42) |
| Tax Provision | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | (27.64) | (26.24) | (16.18) | (14.18) | (17.71) | (15.17) | (15.20) | (16.78) | (16.03) | (13.42) |
| Basic EPS | (0.65) | (0.80) | (0.46) | (0.52) | (0.65) | (0.56) | (0.52) | (0.62) | (0.60) | (0.76) |
| Diluted EPS | (0.65) | (0.80) | (0.46) | (0.52) | (0.65) | (0.56) | (0.52) | (0.62) | (0.60) | (0.76) |
← Scroll for more columns →
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | (19.76) | (27.09) | (11.52) | (9.92) | (13.78) | (16.56) | (13.02) | (11.73) | (11.69) | (10.98) |
| Capital Expenditures | 0.00 | 0.56 | 0.00 | 0.00 | 0.00 | 0.02 | 0.51 | 1.00 | 0.34 | 0.22 |
| Free Cash Flow* | (19.76) | (27.65) | (11.52) | (9.92) | (13.78) | (16.58) | (13.53) | (12.73) | (12.03) | (11.21) |
| Investing Cash Flow | 0.00 | (0.56) | 0.00 | 0.00 | 0.00 | (0.02) | (0.51) | (1.00) | (0.34) | (0.22) |
| Financing Cash Flow | (0.27) | 114.94 | 50.19 | 0.15 | 0.61 | 9.13 | 0.05 | 1.32 | (0.23) | 134.56 |
← Scroll for more columns →
* Derived from reported values